Inhaled granisetron passes first safety check in healthy volunteers

NCT ID NCT04200092

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested an inhaled form of granisetron (called AZ-010) in 36 healthy adults to see if it is safe and how the body absorbs it. Participants received either a single inhaled dose of AZ-010 (at different strengths), a placebo, or an IV injection of granisetron for comparison. The goal was to gather safety data and measure drug levels in the blood, not to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Staccato Granisetron (AZ-010) – an inhaled form of the drug granisetron

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • Celerion

    Tempe, Arizona, 85283, United States